The effects of novel fluorinated tamoxifens in human breast cancer cell lines

The effects of novel fluorinated tamoxifens in human breast cancer cell lines

Bibliographic Details
Main Author:	Jones, Carolyn Elizabeth
Published:	University of Birmingham 2005
Subjects:	616.99449061
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.433640

Similar Items

Characterisation of genes associated with tamoxifen resistance
by: Maraqa, Loaie
Published: (2010)

Cytotoxic activity of Fagonia cretica against human breast cancer cells
by: Lam, Matthew
Published: (2012)

Purification and characterisation of malignant epithelial cells from human primary breast cancers
by: Kothari, Manish
Published: (2007)

Anti-tumour effects of bisphosphonates in breast cancer
by: Jagdev, Satinder P. K.
Published: (2004)

The role of adamalysins in the shedding of syndecan-1 from breast cancer cells
by: Ntounia-Fousara, Sofia
Published: (2005)

Determining the genes responsible for drug resistance in ovarian and breast cancer stem cells
by: Eyre, Rachel
Published: (2012)

Investigation of potential pro-apoptotic and differentiating therapeutic modalities in breast cancer cells
by: Crabb, Simon John
Published: (2006)

Investigation into the therapeutic potential of novel cyclin dependent kinase (CDK) inhibitors in the treatment of antiestrogen sensitive and resistant breast cancer
by: Johnson, Neil
Published: (2006)

Analysis of drug resistance markers in primary breast cancer
by: Barrett, Sophie Victoria
Published: (2005)

Vitamin D receptor signalling is disrupted in breast cancer
by: Banwell, Claire
Published: (2005)

Characterization of genetic events involved in docetaxel resistance in breast cancer
by: McDonald, Sarah L.
Published: (2005)

Evaluation of the vascular response to neoadjuvant chemotherapy in primary breast cancer
by: Ah-See, Mei-Lin Wong
Published: (2007)

Biomarkers for the evaluation of hormonal strategies for prevention and treatment of breast cancer
by: Harper-Wynne, Catherine Linda
Published: (2004)

The role of epidermal growth factor receptor inhibition in endocrine-responsive breast cancer
by: Polychronis, Andreas
Published: (2007)

The role of the oestrogen receptor interacting proteins, FKBPL and RBCK1, in breast cancer signalling
by: Donley, Christopher Blair
Published: (2013)

Disruption of CXCL12/CXCR4 interactions : a role in breast cancer therapy?
by: Mellor, Paul
Published: (2006)

PI3K signalling blockade : a target for chemotherapeutic enhancement in breast cancer
by: McCarragher, Leeza Sarah Marie
Published: (2003)

The synthesis of steroidal and non-steroidal steroid sulphatase inhibitors for endocrine therapy of breast cancer
by: Hejaz, Hatem Amin Moh'd
Published: (1998)

The tumour suppressor P53 and apoptotic regulatory proteins in breast cancer survival and response to therapy
by: Hinnis, Adel Rady
Published: (2005)

Prediction of response of patients with breast cancer to neoadjuvant chemotherapy using advanced magnetic resonance imaging
by: Pickles, Martin Darren
Published: (2006)

The utilisation of scintimammography with 99m-technetium sestamibi to minitor and predict response to neoadjuvant chemotherapy in breast cancer
by: Marshall, Christopher
Published: (2004)

Quantum dot-labelled antibody to quantify expression of the EGF family of receptors and ligands in breast cancer specimens
by: Zona, Stefania
Published: (2013)

The impact of survival signalling blockade on chemotherapy in human cancer
by: Wang, Yan Amber
Published: (2007)

The proteomic analysis of resistance to anticancer therapy in human breast cancer
by: Smith, Laura
Published: (2006)

Evaluation of proton magnetic resonance spectroscopy in predicting treatment response of malignant breast lesions
by: Tan, Peuen Clara
Published: (2005)

Genetic immunotherapy for cancer
by: Michael, Agnieszka
Published: (2006)

The effects of selective oestrogen receptor modulators in the uterus
by: Gray, Douglas Thomas
Published: (2006)

STAT1 : a modulator of chemotherapy induced apoptosis
by: Thomas, M.
Published: (2005)

Non steroidal anti-inflammatory drugs (NSAIDs) and neoplasms in women : trends, risk and progression
by: Glover, Janine Avril
Published: (2013)

NFÎºB : a critical mediator of BRCA1 chemoresistence
by: Purcell, James
Published: (2006)

Identification of genes associated with the maintenance of the tamoxifen resistant breast cancer cell phenotype following tamoxifen withdrawal
by: Stone, Andrew
Published: (2008)

Effects of long-term tamoxifen treatment on ERa expression in breast cancer cells
by: Bensmail, Abdelwahab
Published: (2009)

Microarray analysis of tamoxifen resistance in breast cancer
by: Moss, Charlotte
Published: (2009)

A two part study to investigate the morbidity and mortality of long-term tamoxifen therapy in women with breast cancer and the effects of exposure to exogenous oestrogens in women with benign and malignant breast disease
by: McDonald, Carolyn
Published: (2000)

Expression and role of protein kinase C isoforms in tamoxifen resistant breast cancer
by: Lewis, Ian
Published: (2005)

Endocrine agents in breast cancer : studies of tamoxifen and a new aromatase inhibitor
by: Love, Corinne D. B.
Published: (2000)

FXR activation induces mitochondrial mediated apoptosis in breast cancer and synergizes with tamoxifen
by: Mohan, Rati
Published: (2016)

Molecular gene expression and genome wide profiling in tamoxifen-resistant breast cancer
by: Yeoh, Chit Cheng
Published: (2010)

Role of insulin-like growth factor (IGF) axis in the development of tamoxifen resistance in breast cancer epithelial cells
by: Hawsawi, Yousef Mohammed Rabaa
Published: (2015)

Genotoxicity of tamoxifen and structural analogues of tamoxifen : studies on the activation of tamoxifen by cytochrome P450s and peroxidase
by: Davies, Adrian M.
Published: (1999)